Impact of Berotralstat on Hereditary Angioedema Attack Rates in Patients with C1-Inhibitor Deficiency: Real-World Evidence Stratified by Prior Long-Term Prophylaxis

Orladeyo (berotralstat) - BioCryst Pharmaceuticals

https://events.rdmobile.com/Lists/Details/3220787

Raffi Tachdjian MD MPH FAAAAI 1; Mark Davis-Lorton MD FAAAAI 2; Tracy Yee 3; Francois Laliberte 4; Robert Schell 4; Sandra Nestler-Parr 3; Patrick Gillard 5; William Lumry MD FAAAAI 6

Feb 10, 2026